Information  X 
Enter a valid email address

Cropper(James) PLC (CRPR)

  Print      Mail a friend

Wednesday 17 July, 2019

Cropper(James) PLC

Director/PDMR Shareholding

RNS Number : 8403F
Cropper(James) PLC
17 July 2019
 

 

17 July 2019

James Cropper plc

(the "Company")

 

Directors' Dealings

 

The Company was notified on 16 July 2019 that on the same day, Phil Wild, Chief Executive, purchased 6,000 ordinary shares of 25p each in the Company ("Shares") and Mark Cropper, Chairman, purchased 39,000 Shares, in each case at a price of 1,050p per Share. In addition, the Company was today notified that, on 17 July 2019, Mark Cropper acquired 1,400 Shares from a member of the Cropper family, at a price of 1,050p per Share.

 

As a result of the above, Phil Wild's beneficial interest in the Company has increased by 6,000 Shares, and Mark Cropper's resultant interest in the Company is as follows:

 

 Director

Beneficial Shareholding

% of Issued Share Capital

Non-beneficial Shareholding

% of Issued Share Capital

Mark Cropper

1,828,088*

19.1%

559,571

5.9%

 * Includes 486,924 Shares pledged as security.

The members of the Cropper family and Mark Cropper are deemed to be acting in concert and regarded by the Takeover Panel to be members of the concert party detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party"). The total resultant interest of the Concert Party, directly and indirectly comprises 3,608,693 Shares, representing 37.8% of the issued share capital of the Company.

 

Enquiries:

James Cropper PLC (AIM: CRPR)

Isabelle Maddock, Group Finance Director

Jim Aldridge, Company Secretary

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

     Shore Capital

     Robert Finlay, Henry Willcocks

     Richard Johnson

     Tel:  + 44 (0) 207 408 4090

    

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLIFSADVIDLIA

a d v e r t i s e m e n t